We are excited to share that Elena has joined the Early Career Researcher (ECR) Board of ACS Medicinal Chemistry Letters! This will be a two-year term role starting this January 2026.
ACS Medicinal Chemistry Letters is a leading journal of the American Chemical Society that reports high-impact findings at the interface of chemistry, biology, and drug discovery. The journal is peer-reviewed and focuses specifically on medicinal chemistry and drug discovery, publishing high-quality, concise reports on innovative and exciting research in the field. As a member of the ECR Board, Elena will contribute to supporting the journal’s mission, engaging with the medicinal chemistry community, and highlighting emerging research and perspectives from early career scientists. As medicinal chemistry is core to our research interests and ongoing activities, Elena is particularly keen to bring forward the vision of emerging ECR researchers in the field.
The EDV group is looking forward to contributing to the journal and engaging with the broader medicinal chemistry community in the coming couple of years.
EDV Lab 